Familial pituitary adenomas - Who should be tested for AIP mutations?

Clinical Endocrinology

Volumn 77, Issue 3, 2012, Pages 351-356

  Korbonits, Márta ^a   Storr, Helen ^a   Kumar, Ajith V ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOSTATIN;

AIP GENE; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; FAMILIAL ISOLATED PITUITARY ADENOMA; FAMILY HISTORY; GENE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; HYPOPHYSIS ADENOMA; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SOMATIC MUTATION; TREATMENT RESPONSE;

ADENOMA; ADOLESCENT; ADULT; AGE OF ONSET; CHILD; FEMALE; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PITUITARY NEOPLASMS; YOUNG ADULT;

EID: 84865016013     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04445.x     Document Type: Article

References (41)

1. Couldwell, W.T., &, Cannon-Albright, L., (2010) A heritable predisposition to pituitary tumors. Pituitary, 13, 130-137.
2. Chahal, H.S., Chapple, J.P., Frohman, L.A., et al,. (2010) Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA). Trends in Endocrinology and Metabolism, 21, 419-427.
3. Xekouki, P., Azevedo, M., &, Stratakis, C.A., (2010) Anterior pituitary adenomas: inherited syndromes, novel genes and molecular pathways. Expert Review of Endocrinology and Metabolism, 5, 697-709.
4. Wildi-Runge, S., Bahubeshi, A., Carret, S., et al,. (2011) New phenotype in the familial DICER1 tumor syndrome: pituitary blastoma presenting at age 9 months. Endocrine Reviews, 32 (03-MeetingAbstracts), P1-P777 (Abstract).
5. Brahma, A., Heyburn, P., &, Swords, F., (2009) Familial prolactinoma occuring in association with SDHB mutation positive paraganglioma. Endocrine Abstracts Spring, 19, P239 (Abstract).
6. Denes, J., Swords, F.M., Xekouki, P., et al,. (2012) Familial pituitary adenoma and paraganglioma syndrome-a novel type of multiple endocrine neoplasia. Endocrine Reviews, 33 (04-MeetingAbstracts) OR41-2, (Abstract).
7. Varsavsky, M., Sebastian-Ochoa, A., &, Vela, E. Torres, (2012) Coexistence of a pituitary macroadenoma and multicentric paraganglioma: A strange coincidence. Endocrinology Nutrition, 2012, DOI: 10.1016/j.endonu.2012. 02.009.
8. Xekouki, P., Pacak, K., Almeida, M., et al,. (2012) Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH? Journal of Clinical Endocrinology and Metabolism, 97, E357-E366.
9. Vierimaa, O., Georgitsi, M., Lehtonen, R., et al,. (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science, 312, 1228-1230.
10. Daly, A.F., Jaffrain-Rea, M.L., Ciccarelli, A., et al,. (2006) Clinical characterization of familial isolated pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 91, 3316-3323.
11. Daly, A.F., Vanbellinghen, J.F., Khoo, S.K., et al,. (2007) Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. Journal of Clinical Endocrinology and Metabolism, 92, 1891-1896.
12. Leontiou, C.A., Gueorguiev, M., van der Spuy, J., et al,. (2008) The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 93, 2390-2401.
13. Igreja, S., Chahal, H.S., King, P., et al,. (2010) Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Human Mutation, 31, 950-960.
14. Daly, A.F., Tichomirowa, M.A., Petrossians, P., et al,. (2010) Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. Journal of Clinical Endocrinology and Metabolism, 95, E373-E383.
15. Tichomirowa, M.A., Barlier, A., Daly, A.F., et al,. (2011) High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. European Journal of Endocrinology, 165, 509-515.
16. Cazabat, L., Bouligand, J., Salenave, S., et al,. (2012) Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients. Journal of Clinical Endocrinology and Metabolism, 97, E663-E670.
17. Chahal, H.S., Trivellin, G., Leontiou, C.A., et al,. (2012) Somatostatin analogs modulate AIP in somatotroph adenomas-the role of the ZAC1 pathway. Journal of Clinical Endocrinology and Metabolism, doi: 10.1210/jc.2012-1111.
18. Chahal, H.S., Stals, K., Unterlander, M., et al,. (2011) AIP mutation in pituitary adenomas in the 18th century and today. New England Journal of Medicine, 364, 43-50.
19. Villa, C., Lagonigro, M.S., Magri, F., et al,. (2011) Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein (AIP) gene mutation. Endocrine Related Cancer, 13, 347-356.
20. Garay, I.B., Coca, M.A., Daly, A.F., et al,. (2011) A novel AIP mutation related to familial isolated pituitary Adenomas (FIPA). Endocrine Reviews, 32 (03-MeetingAbstracts), P1-P424 (Abstract).
21. Xekouki, P., Mastroyannis, A., Lysikatos, C., et al,. (2011) Apoplexy of a silent pituitary adenoma as the only presentation of a novel AIP mutation in a greek family with familial isolated pituitary adenoma. Endocrine Reviews, 32 (03-MeetingAbstracts), P1-P437 (Abstract).
22. Naves, L.A., Daly, A.F., Vanbellinghen, J.F., et al,. (2007) Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene. European Journal of Endocrinology, 157, 383-391.
23. Occhi, G., Trivellin, G., Ceccato, F., et al,. (2010) Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia. European Journal of Endocrinology, 163, 369-376.
24. Georgitsi, M., De Menis, E., Cannavo, S., et al,. (2008) Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas. Clinical Endocrinology, 69, 621-627.
25. Stratakis, C.A., Tichomirowa, M.A., Boikos, S., et al,. (2010) The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clinical Genetics, 78, 457-463.
26. Cazabat, L., Libe, R., Perlemoine, K., et al,. (2007) Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. European Journal of Endocrinology, 157, 1-8.
27. Cazabat, L., Bouligand, J., &, Chanson, P., (2011) AIP mutation in pituitary adenomas. New England Journal of Medicine, 364, 1973-1974.
28. Georgitsi, M., Karhu, A., Winqvist, R., et al,. (2007) Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers. British Journal of Cancer, 96, 352-356.
29. Raitila, A., Georgitsi, M., Karhu, A., et al,. (2007) No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia. Endocrine Related Cancer, 14, 901-906.
30. Heliovaara, E., Raitila, A., Launonen, V., et al,. (2009) The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomas. American Journal of Pathology, 175, 2501-2507.
31. Stals, K., Trivellin, G., &, Korbonits, M., (2011) AIP mutation in pituitary adenomas. New England Journal of Medicine, 364, 1974-1975.
32. Occhi, G., Jaffrain-Rea, M.L., Trivellin, G., et al,. (2010) The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: mutational hot-spot or founder effect? Journal of Endocrinological Investigation, 33, 800-805.
33. Daly, A.F., Rixhon, M., Adam, C., et al,. (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. Journal of Clinical Endocrinology and Metabolism, 91, 4769-4775.
34. Fernandez, A., Karavitaki, N., &, Wass, J.A., (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clinical Endocrinology, 72, 377-382.
35. Raappana, A., Koivukangas, J., Ebeling, T., et al,. (2010) Incidence of pituitary adenomas in Northern Finland in 1992-2007. Journal of Clinical Endocrinology and Metabolism, 95, 4268-4275.
36. Fontana, E., &, Gaillard, R., (2009) [Epidemiology of pituitary adenoma: results of the first Swiss study]. Revue Médicale Suisse, 5, 2172-2174.
37. Ezzat, S., Asa, S.L., Couldwell, W.T., et al,. (2004) The prevalence of pituitary adenomas: a systematic review. Cancer, 101, 613-619.
38. Thakker, R.V., Newey, P.J., Walls, G.V., et al,. (2012) Clinical practice guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1). Journal of Clinical Endocrinology and Metabolism, doi: 10.1210/jc.2012-1230.
39. Korbonits, M., (2012) Tracing back a gene's influence. Endocrine Abstracts, 29, S22.2 (Abstract).
40. Toledo, R.A., Lourenco, D.M. Jr, Liberman, B., et al,. (2007) Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma. Journal of Clinical Endocrinology and Metabolism, 92, 1934-1937.
41. Hernández-Ramírez, L.C., &, Korbonits, M., (2012) Familial pituitary adenomas. In:, E.A. Lawson, S. Ezzat, S.L. Asa, L.M. Rio, L. Michel, eds. Pituitary Disorders: Diagnosis and Management. Wiley-Blackwell, Oxford, 2012.